FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q92910688> ?p ?o ?g. }

• Q92910688 description "article scientifique publié en 2019" @default.
• Q92910688 description "artículu científicu espublizáu n'agostu de 2019" @default.
• Q92910688 description "scientific article published on 28 August 2019" @default.
• Q92910688 description "wetenschappelijk artikel" @default.
• Q92910688 description "наукова стаття, опублікована 28 серпня 2019" @default.
• Q92910688 name "Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)" @default.
• Q92910688 name "Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)" @default.
• Q92910688 type Item @default.
• Q92910688 label "Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)" @default.
• Q92910688 label "Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)" @default.
• Q92910688 prefLabel "Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)" @default.
• Q92910688 prefLabel "Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)" @default.
• Q92910688 P1433 Q92910688-CCE46A37-2733-4D67-AA4C-2F60913F0CE3 @default.
• Q92910688 P1476 Q92910688-B8BB0B0E-B236-46DB-9CD5-7BFE9A02A7BD @default.
• Q92910688 P2093 Q92910688-18ECE972-12FC-422A-B5BF-5D2060DF301F @default.
• Q92910688 P2093 Q92910688-2DC18E76-4116-46D1-86BD-BF25A396AE83 @default.
• Q92910688 P2093 Q92910688-33914310-5F00-43F1-9DEE-6579AD2429A3 @default.
• Q92910688 P2093 Q92910688-367F59DA-8806-4932-A63D-742DF2CBBBBA @default.
• Q92910688 P2093 Q92910688-3887D092-1646-40DF-B5E1-07D8FBADAA2A @default.
• Q92910688 P2093 Q92910688-3D25A712-2220-42A2-854A-F893485B1EC5 @default.
• Q92910688 P2093 Q92910688-4E72F049-B41E-4C15-8A7B-75002AE2FEF2 @default.
• Q92910688 P2093 Q92910688-655CD954-C50D-4029-B6E2-BDC4976557EC @default.
• Q92910688 P2093 Q92910688-687C18CF-6EE9-4482-B1FB-DB41ECA14C9C @default.
• Q92910688 P2093 Q92910688-69461ED4-459A-410D-A01A-431C123D9750 @default.
• Q92910688 P2093 Q92910688-73B918BC-0FB8-4BCF-A73B-84DD9EF80E18 @default.
• Q92910688 P2093 Q92910688-7B5B3B1B-D11D-47B6-A43D-1321BD532FC0 @default.
• Q92910688 P2093 Q92910688-8138D32D-B5B7-4AA7-987D-87A5115353F1 @default.
• Q92910688 P2093 Q92910688-89F0776F-4CC7-46D2-B6CD-45C46797BD2E @default.
• Q92910688 P2093 Q92910688-A0B364B6-34F3-4362-8472-C80625C3D503 @default.
• Q92910688 P2093 Q92910688-C3241CD0-3B41-4E2E-8457-A466B91306CF @default.
• Q92910688 P2093 Q92910688-CD32B5D4-D6B7-4FFC-ABC6-3B20DBEEA7ED @default.
• Q92910688 P2093 Q92910688-DFCB7916-129A-48AB-A7AC-7234ABA50F0C @default.
• Q92910688 P2093 Q92910688-EFAC6DB2-8C02-47A8-A0FF-5581C6E4A386 @default.
• Q92910688 P2860 Q92910688-02A635BF-FDF0-48F2-8BC4-E8117461F8FC @default.
• Q92910688 P2860 Q92910688-04C75DC5-FB82-4AD6-A190-97A7256437A7 @default.
• Q92910688 P2860 Q92910688-0DB5E55D-AFEC-4D10-8A1F-074A64E75086 @default.
• Q92910688 P2860 Q92910688-12FA470B-B794-4BE3-867C-86B6B568AF93 @default.
• Q92910688 P2860 Q92910688-15372F46-A6AD-4ED6-931D-44B75C68F363 @default.
• Q92910688 P2860 Q92910688-18F505A6-A112-4CF3-93D0-9136A5A5F2B7 @default.
• Q92910688 P2860 Q92910688-1A5F127D-0065-46BA-B99A-CFCD10F2968A @default.
• Q92910688 P2860 Q92910688-1DBFD388-EE59-456D-85A1-5B85D48EC73C @default.
• Q92910688 P2860 Q92910688-20C289F4-9C4C-4E40-A351-FF567C539C54 @default.
• Q92910688 P2860 Q92910688-253E9EAD-2AD3-4D75-A3DC-4E529F7DDEE0 @default.
• Q92910688 P2860 Q92910688-28001930-ADBD-4F25-9CAF-ECA54B6ECAA8 @default.
• Q92910688 P2860 Q92910688-2A493B5D-8B6C-43A9-9B5D-A09AB2F32D00 @default.
• Q92910688 P2860 Q92910688-32371782-4C25-475E-8B0C-9BAAA6C3067A @default.
• Q92910688 P2860 Q92910688-3388F48E-39B1-469C-AA0D-7890160C7BD9 @default.
• Q92910688 P2860 Q92910688-38B9C6BC-E56B-405F-BA90-116C72A3D6D9 @default.
• Q92910688 P2860 Q92910688-4BB74401-4CFE-426E-9F1B-561C6F152E27 @default.
• Q92910688 P2860 Q92910688-4BEAEFA4-BAD1-4C8C-B7CE-A2B936974A0D @default.
• Q92910688 P2860 Q92910688-539C4E78-C3E0-487A-8687-9B07D74DD23C @default.
• Q92910688 P2860 Q92910688-5A1ADD6B-CEDA-44A1-A1E0-0D2710D44474 @default.
• Q92910688 P2860 Q92910688-60658A48-1865-4CC7-9317-F5408536C6F8 @default.
• Q92910688 P2860 Q92910688-7AE13599-C3E8-4AA8-8E90-80C7236D89EF @default.
• Q92910688 P2860 Q92910688-7B6B91CE-3544-4245-8EBB-2C02A6BF5618 @default.
• Q92910688 P2860 Q92910688-89C6CFDA-14AA-47C6-A8B2-DEEB04638FA9 @default.
• Q92910688 P2860 Q92910688-A1CCA884-964C-4BC5-ADD1-E08E002A03C0 @default.
• Q92910688 P2860 Q92910688-A43DA7A8-E55E-4FDF-B939-ED7CCEF80766 @default.
• Q92910688 P2860 Q92910688-B3247838-5B2B-4B78-A229-9A8E695E1505 @default.
• Q92910688 P2860 Q92910688-B4D9D558-F873-4962-8159-25CB419DF9ED @default.
• Q92910688 P2860 Q92910688-BD0626BC-FF4C-4125-A9FA-FF1C9E35F035 @default.
• Q92910688 P2860 Q92910688-CE2D1F09-BC43-47A1-89CB-513089838B50 @default.
• Q92910688 P2860 Q92910688-DB7FE610-43EE-4127-BA6C-265F4B4DA038 @default.
• Q92910688 P2860 Q92910688-DED9DBC4-DB16-4129-AA78-2BE34A436067 @default.
• Q92910688 P2860 Q92910688-E5230FEE-C2F7-407A-B5CE-1B8D0504818F @default.
• Q92910688 P2860 Q92910688-EED08619-8DEE-4DD0-BC91-0D6153F1ED74 @default.
• Q92910688 P2860 Q92910688-EF0266CE-7693-4B6F-99D5-DE81895A8A94 @default.
• Q92910688 P2860 Q92910688-FD6FAC75-A1E5-4743-B3F1-64F3267C832B @default.
• Q92910688 P304 Q92910688-79201A24-0F86-47A5-9F8F-71D2CC0F0B10 @default.
• Q92910688 P31 Q92910688-A6728E2F-9135-4752-9F83-47930382195A @default.
• Q92910688 P356 Q92910688-5B0ECEBD-4EA1-4441-A01E-FC051F56B338 @default.
• Q92910688 P433 Q92910688-95BC12F6-21E2-4DD8-9A5C-C26BA1427896 @default.
• Q92910688 P478 Q92910688-95C0294E-2BF9-4739-8608-1D337DA15E86 @default.
• Q92910688 P50 Q92910688-D2A71146-BC5E-415E-A581-C6C0028EC522 @default.
• Q92910688 P577 Q92910688-321B5FD9-31BF-4187-833A-3C59B05F05F4 @default.
• Q92910688 P698 Q92910688-E50C978B-915D-462A-87BD-44AD91566357 @default.
• Q92910688 P921 Q92910688-186E7387-59D6-448F-A173-9647975900D3 @default.
• Q92910688 P932 Q92910688-BE317FD3-08C9-4C4E-BAA6-76E43F721A7B @default.
• Q92910688 P356 S13058-019-1180-6 @default.
• Q92910688 P698 31455425 @default.
• Q92910688 P1433 Q2208481 @default.
• Q92910688 P1476 "Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)" @default.
• Q92910688 P2093 "Ayoub Charehbili" @default.
• Q92910688 P2093 "Birgit E P J Vriens" @default.
• Q92910688 P2093 "Dutch Breast Cancer Research Group" @default.
• Q92910688 P2093 "Elma Meershoek-Klein Kranenbarg" @default.
• Q92910688 P2093 "Gerrit-Jan Liefers" @default.
• Q92910688 P2093 "Hanneke W M van Laarhoven" @default.
• Q92910688 P2093 "Hanno Pijl" @default.
• Q92910688 P2093 "Jacobus J M van der Hoeven" @default.
• Q92910688 P2093 "Joan B Heijns" @default.
• Q92910688 P2093 "Johan W R Nortier" @default.
• Q92910688 P2093 "Judith R Kroep" @default.
• Q92910688 P2093 "Laurence J C van Warmerdam" @default.
• Q92910688 P2093 "Lonneke W Kessels" @default.
• Q92910688 P2093 "M Wouter Dercksen" @default.
• Q92910688 P2093 "Manon J A E Pepels" @default.
• Q92910688 P2093 "Marta Fiocco" @default.
• Q92910688 P2093 "Saskia van de Ven" @default.
• Q92910688 P2093 "Stefanie de Groot" @default.

• next